Literature DB >> 28153834

Fall of the mutants: T cells targeting BCR-ABL.

Premal Lulla1,2,3, Helen E Heslop1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28153834      PMCID： PMC5290991          DOI： 10.1182/blood-2016-12-757336

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Authors:  Barbara Wassmann; Heike Pfeifer; Nicola Goekbuget; Dietrich W Beelen; Joachim Beck; Matthias Stelljes; Martin Bornhäuser; Albrecht Reichle; Jolanta Perz; Rainer Haas; Arnold Ganser; Mathias Schmid; Lothar Kanz; Georg Lenz; Martin Kaufmann; Anja Binckebanck; Patrick Brück; Regina Reutzel; Harald Gschaidmeier; Stefan Schwartz; Dieter Hoelzer; Oliver G Ottmann
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Neoantigen landscape dynamics during human melanoma-T cell interactions.

Authors:  Els M E Verdegaal; Noel F C C de Miranda; Marten Visser; Tom Harryvan; Marit M van Buuren; Rikke S Andersen; Sine R Hadrup; Caroline E van der Minne; Remko Schotte; Hergen Spits; John B A G Haanen; Ellen H W Kapiteijn; Ton N Schumacher; Sjoerd H van der Burg
Journal:  Nature       Date:  2016-06-27       Impact factor: 49.962

3.  BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors.

Authors:  Patrizia Comoli; Sabrina Basso; Giovanni Riva; Patrizia Barozzi; Ilaria Guido; Antonella Gurrado; Giuseppe Quartuccio; Laura Rubert; Ivana Lagreca; Daniela Vallerini; Fabio Forghieri; Monica Morselli; Paola Bresciani; Angela Cuoghi; Ambra Paolini; Elisabetta Colaci; Roberto Marasca; Antonio Cuneo; Lorenzo Iughetti; Tommaso Trenti; Franco Narni; Robin Foà; Marco Zecca; Mario Luppi; Leonardo Potenza
Journal:  Blood       Date:  2016-12-07       Impact factor: 22.113

4.  Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.

Authors:  Cyrille J Cohen; Jared J Gartner; Miryam Horovitz-Fried; Katerina Shamalov; Kasia Trebska-McGowan; Valery V Bliskovsky; Maria R Parkhurst; Chen Ankri; Todd D Prickett; Jessica S Crystal; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

5.  Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment.

Authors:  Giovanni Riva; Mario Luppi; Patrizia Barozzi; Chiara Quadrelli; Sabrina Basso; Daniela Vallerini; Eleonora Zanetti; Monica Morselli; Fabio Forghieri; Monica Maccaferri; Francesco Volzone; Cinzia Del Giovane; Roberto D'Amico; Franco Locatelli; Giuseppe Torelli; Patrizia Comoli; Leonardo Potenza
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

Review 6.  Toxicities of chimeric antigen receptor T cells: recognition and management.

Authors:  Jennifer N Brudno; James N Kochenderfer
Journal:  Blood       Date:  2016-05-20       Impact factor: 22.113

7.  Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors.

Authors:  Dan Jones; Deborah Thomas; C Cameron Yin; Susan O'Brien; Jorge E Cortes; Elias Jabbour; Megan Breeden; Francis J Giles; Weiqiang Zhao; Hagop M Kantarjian
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

8.  T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.

Authors:  Eric Tran; Paul F Robbins; Yong-Chen Lu; Todd D Prickett; Jared J Gartner; Li Jia; Anna Pasetto; Zhili Zheng; Satyajit Ray; Eric M Groh; Isaac R Kriley; Steven A Rosenberg
Journal:  N Engl J Med       Date:  2016-12-08       Impact factor: 91.245

9.  Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.

Authors:  Nicholas McGranahan; Andrew J S Furness; Rachel Rosenthal; Sofie Ramskov; Rikke Lyngaa; Sunil Kumar Saini; Mariam Jamal-Hanjani; Gareth A Wilson; Nicolai J Birkbak; Crispin T Hiley; Thomas B K Watkins; Seema Shafi; Nirupa Murugaesu; Richard Mitter; Ayse U Akarca; Joseph Linares; Teresa Marafioti; Jake Y Henry; Eliezer M Van Allen; Diana Miao; Bastian Schilling; Dirk Schadendorf; Levi A Garraway; Vladimir Makarov; Naiyer A Rizvi; Alexandra Snyder; Matthew D Hellmann; Taha Merghoub; Jedd D Wolchok; Sachet A Shukla; Catherine J Wu; Karl S Peggs; Timothy A Chan; Sine R Hadrup; Sergio A Quezada; Charles Swanton
Journal:  Science       Date:  2016-03-03       Impact factor: 47.728
  9 in total
  1 in total

Review 1.  Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies.

Authors:  Vincenzo Nasillo; Giovanni Riva; Ambra Paolini; Fabio Forghieri; Luca Roncati; Beatrice Lusenti; Monica Maccaferri; Andrea Messerotti; Valeria Pioli; Andrea Gilioli; Francesca Bettelli; Davide Giusti; Patrizia Barozzi; Ivana Lagreca; Rossana Maffei; Roberto Marasca; Leonardo Potenza; Patrizia Comoli; Rossella Manfredini; Antonino Maiorana; Enrico Tagliafico; Mario Luppi; Tommaso Trenti
Journal:  Int J Mol Sci       Date:  2021-02-14       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.